THOMAS FOGARTY: Open Payments
NPI 1760527469 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 6 payments from 4 companies in 2025. Trend: 2023 $288 · 2024 $242 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $160 |
| E.R. Squibb & Sons, L.L.C. | 1 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $104 |
| ABBVIE INC. | 1 | $14 |
Products named: REXULTI, COBENFY, CAPLYTA, VRAYLAR.
Industry payments across VA — which companies pay providers there.
